Leisure Acquisition

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch LACQU and buy or sell other stocks, options, and ETFs commission-free!

About LACQU

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. 

CEO
D. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees
Employees
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2003
Founded2003
Employees
Employees

LACQU Key Statistics

Market cap
34.04M
Market cap34.04M
Price-Earnings ratio
28.40
Price-Earnings ratio28.40
Dividend yield
Dividend yield
Average volume
25.10
Average volume25.10
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$22.01
52 Week high$22.01
52 Week low
$9.03
52 Week low$9.03
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.